Intellia Therapeutics, Inc. (NTLA)
11.87
-0.15
(-1.25%)
USD |
NASDAQ |
Jan 15, 16:00
12.00
+0.13
(+1.10%)
After-Hours: 20:00
Intellia Therapeutics Market Cap: 1.375B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 3.252B |
| ANI Pharmaceuticals, Inc. | 1.915B |
| Regeneron Pharmaceuticals, Inc. | 77.98B |
| Pacific Biosciences of California, Inc. | 709.48M |
| Twist Bioscience Corp. | 2.529B |
Market Cap Related Metrics
| PS Ratio | 21.63 |
| Price to Book Value | 1.837 |
| Price | 11.87 |
| Earnings Yield | -35.94% |